##common.pageHeaderLogo.altText##

Vol. 3 No. 5 (2023)

Hemogram Parameters and Hemogram-Derived Ratios in Covid-19 Severity

Clinical Medicine And Health Research Journal, Vol. 3 No. 5 (2023), 24 October 2023 , Page 626-631
https://doi.org/10.18535/cmhrj.v3i5.262

Abstract

Background: Understanding the hematological manifestations of the COVID-19, is of paramount importance in terms of patient management and prognosis.


Aim: To review the fundamental hemogram parameters and their clinical significance.


Methods: This is a retrospective, cross-sectional, and observational investigation. Hemogram findings of the participants within 30 days following the onset of symptoms were analyzed. Participants were categorized into moderate and severe groups based on the assessment of disease severity.


Results: Both erythrocyte sedimentation rate and C-reactive protein are considerably elevated in both groups, with higher levels observed in the severe group compared to the moderate group. The percentage of neutrophils, is elevated above normal in both groups, with the severe group demonstrating higher values. The statistical difference between the groups is significant.


Conclusion: Hemogram-derived ratios would be beneficial to include them in common laboratory practices.

Keywords:
  • Severity of COVID-19, hemogram parameters, hemogram-derived ratios.

How to Cite

TOK, D., & BAKIR, F. . (2023). Hemogram Parameters and Hemogram-Derived Ratios in Covid-19 Severity. Clinical Medicine And Health Research Journal, 3(5), 626–631. https://doi.org/10.18535/cmhrj.v3i5.262

Download Citation

References

  • Shi Y, Wang G, Cai X-P, Deng J-W, Zheng L, Zhu H-H, et al. An overview of COVID-19. J Zhejiang Univ Sci B. 2020 May;21(5):343–60.
  • Avila E, Kahmann A, Alho C, Dorn M. Hemogram data as a tool for decision-making in COVID-19 management: applications to resource scarcity scenarios. PeerJ. 2020;8:e9482.
  • Segalo S, Kiseljakovic E, Papic E, Joguncic A, Pasic A, Sahinagic M, et al. The Role of Hemogram-derived Ratios in COVID-19 Severity Stratification in a Primary Healthcare Facility. Acta Inform medica AIM J Soc Med Informatics Bosnia Herzegovina Cas Drus za Med Inform BiH. 2023 Mar;31(1):41–7.
  • Zhao Q, Meng M, Kumar R, Wu Y, Huang J, Deng Y, et al. Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2020 Jul;96:131–5.
  • Xu P, Zhou Q, Xu J. Mechanism of thrombocytopenia in COVID-19 patients. Ann Hematol. 2020 Jun;99(6):1205–8.
  • Abd El-Lateef AE, Ismail MM, Thabet G, Cabrido N-A. Complete blood cells count abnormalities in COVID-19 patients and their prognostic significance: Single center study in Makkah, Saudi Arabia. Saudi Med J. 2022 Jun;43(6):572–8.
  • Feng X, Li S, Sun Q, Zhu J, Chen B, Xiong M, et al. Immune-inflammatory parameters in COVID-19 cases: a systematic review and meta-analysis. Front Med. 2020;7:301.
  • Słomka A, Kowalewski M, Żekanowska E. Coronavirus disease 2019 (COVID–19): A short review on hematological manifestations. Pathogens. 2020;9(6):493.
  • Bellou V, Tzoulaki I, van Smeden M, Moons KGM, Evangelou E, Belbasis L. Prognostic factors for adverse outcomes in patients with COVID-19: a field-wide systematic review and meta-analysis. Eur Respir J. 2022;59(2).
  • Sudre CH, Lee KA, Ni Lochlainn M, Varsavsky T, Murray B, Graham MS, et al. Symptom clusters in COVID-19: A potential clinical prediction tool from the COVID Symptom Study app. Sci Adv. 2021;7(12):eabd4177.
  • Kermali M, Khalsa RK, Pillai K, Ismail Z, Harky A. The role of biomarkers in diagnosis of COVID-19–A systematic review. Life Sci. 2020;254:117788.
  • Rasband WS. US National Institutes of Health. http//imagej nih gov/ij/. 2011;
  • Suárez-Del-Villar-Carrero R, Martinez-Urbistondo D, Cuevas-Sierra A, Ibañez-Sustacha I, Candela-Fernandez A, Dominguez-Calvo A, et al. Hematological- and Immunological-Related Biomarkers to Characterize Patients with COVID-19 from Other Viral Respiratory Diseases. J Clin Med. 2022 Jun;11(13).
  • Aghbash PS, Rasizadeh R, Shirvaliloo M, Nahand JS, Baghi HB. Dynamic alterations in white blood cell counts and SARS-CoV-2 shedding in saliva: an infection predictor parameter. Front Med. 2023;10:1208928.
  • Huang I, Pranata R. Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis. J intensive care. 2020;8:36.
  • Russo A, Tellone E, Barreca D, Ficarra S, Laganà G. Implication of COVID-19 on Erythrocytes Functionality: Red Blood Cell Biochemical Implications and Morpho-Functional Aspects. Int J Mol Sci. 2022 Feb;23(4).
  • Peeling RW, Heymann DL, Teo Y-Y, Garcia PJ. Diagnostics for COVID-19: moving from pandemic response to control. Lancet (London, England). 2022 Feb;399(10326):757–68.
  • Toori KU, Qureshi MA, Chaudhry A, Safdar MF. Neutrophil to lymphocyte ratio (NLR) in COVID-19: A cheap prognostic marker in a resource constraint setting. Pakistan J Med Sci. 2021;37(5):1435–9.
  • Liu G, Zhang S, Hu H, Liu T, Huang J. The role of neutrophil-lymphocyte ratio and lymphocyte–monocyte ratio in the prognosis of type 2 diabetics with COVID-19. Scott Med J [Internet]. 2020 Aug 30;65(4):154–60. Available from: https://doi.org/10.1177/0036933020953516
  • Ravindra R, Ramamurthy P, Aslam S SM, Kulkarni A, K S, Ramamurthy PS. Platelet Indices and Platelet to Lymphocyte Ratio (PLR) as Markers for Predicting COVID-19 Infection Severity. Cureus. 2022 Aug;14(8):e28206.
  • Velazquez S, Madurga R, Castellano JM, Rodriguez-Pascual J, de Aguiar Diaz Obregon SR, Jimeno S, et al. Hemogram-derived ratios as prognostic markers of ICU admission in COVID-19. BMC Emerg Med. 2021 Jul;21(1):89.
  • Wong HYF, Lam HYS, Fong AH-T, Leung ST, Chin TW-Y, Lo CSY, et al. Frequency and Distribution of Chest Radiographic Findings in Patients Positive for COVID-19. Radiology. 2020 Aug;296(2):E72–8.
  • Kaya T, Nalbant A, Kılıçcıoğlu GK, Çayır KT, Yaylacı S, Varım C. The prognostic significance of erythrocyte sedimentation rate in COVID-19. Rev Assoc Med Bras. 2021;67:1305–10.
  • Ahnach M, Zbiri S, Nejjari S, Ousti F, Elkettani C. C-reactive protein as an early predictor of COVID-19 severity. J Med Biochem. 2020;39(4):500.
  • Tonduangu N, Le Borgne P, Lefebvre F, Alame K, Bérard L, Gottwalles Y, et al. Prognostic value of C-reactive protein to lymphocyte ratio (CLR) in emergency department patients with SARS-CoV-2 infection. J Pers Med. 2021;11(12):1274.
  • Castanheira FVS, Kubes P. Neutrophils during SARS-CoV-2 infection: Friend or foe? Immunol Rev. 2023 Mar;314(1):399–412.
  • McKenna E, Wubben R, Isaza-Correa JM, Melo AM, Mhaonaigh AU, Conlon N, et al. Neutrophils in COVID-19: Not Innocent Bystanders. Front Immunol. 2022;13:864387.
    • Article Viewed: 0 Total Download

    ##plugins.themes.ojsPlusA.frontend.article.downloadstatastics##

    Cover Image

    Information